| Bestell-Nr. | Artikelbezeichnung | Chargennummer | CAS-Nummer | Stückpreis € | Menge |
|---|---|---|---|---|---|
|
USP-1362169
Sonderpreis1.059,78 €
|
Levofloxacin Related Compound F (25 mg) ((S)-2,3-Dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid) |
R089T0 | 117620-85-6 | 1.059,78 € | |
|
USP-1362359
Sonderpreis445,18 €
|
Levomethorphan Solution (3 x 1.2 mL) (0.1 mg/mL 3-Methoxy-17-methylmorphinan in methanol) |
R105E0 | 125-70-2 (Levomethorphan) | 445,18 € | |
|
USP-1362624
Sonderpreis1.092,49 €
|
Levonorgestrel-5(10)-ene Isomer (25 mg) |
F25660 | 19914-67-1 | 1.092,49 € | |
|
USP-1362657
Sonderpreis1.279,45 €
|
Levonorgestrel System Suitability Mixture A (15 mg) |
F25840 | N/A | 1.279,45 € | |
|
USP-1362668
Sonderpreis1.080,81 €
|
Levonorgestrel System Suitability Mixture B (15 mg) |
F25850 | NA | 1.080,81 € | |
|
USP-1365043
Sonderpreis1.199,99 €
|
Levothyroxine Peak Identification Mixture (3 x 5 mL) (1 mg/mL |
F114N0 | N/A | 1.199,99 € | |
|
USP-1366080
Sonderpreis949,94 €
|
Lidocaine Related Compound H (50 mg) (2-Chloro-N-(2,6-dimethylphenyl)acetamide) |
R156H0 | 1131-01-7 | 949,94 € | |
|
USP-1366523
Sonderpreis1.139,23 €
|
Linagliptin Related Compound B (15 mg) ((R)-N-(2-Acetylphenyl)-2-[8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl]acetamide) |
F283J0 | 2416949-69-2 | 1.139,23 € | |
|
USP-1366524
Sonderpreis1.139,23 €
|
Linagliptin Related Compound C (15 mg) (7-(But-2-yn-1-yl)-8-[(2-hydroxyethyl)amino]-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-3,7-dihydro-1H-purine-2,6-dione) |
F283K0 | 2074688-84-7 | 1.139,23 € | |
|
USP-1366525
Sonderpreis1.256,08 €
|
Linagliptin Related Compound D (15 mg) ((R,Z)-8-(3-Aminopiperidin-1-yl)-7-(3-bromobut-2-en-1-yl)-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-3,7-dihydro-1H-purine-2,6-dione) |
F283L0 | 1638744-06-5 | 1.256,08 € | |
|
USP-1366526
Sonderpreis1.343,71 €
|
Linagliptin Related Compound E (15 mg) (2-[(R)-3-Aminopiperidine-1-carbonyl]-N-{(R)-1-[7-(but-2-yn-1-yl)-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl]piperidin-3-yl}benzamide) |
F283M0 | 2803370-12-7 | 1.343,71 € |
